Study Name/Name of Institution |
Collaborators |
African American Study of Kidney Disease and Hypertension (AASK) |
Tom Greene, PhD
|
University of Texas Southwestern Medical Center |
Robert Toto, MD |
University Hospital Groningen |
GG van Essen MD |
The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group |
GuiseppeMaschio, MD
|
University of Copenhagen |
Anne Lise Kamper |
Brigham and Women’s Hospital |
Barry M. Brenner |
The Royal Melbourne Hospital,Victoria, Australia |
Benno U. Ihle MBBS, FRACP, FJFICM; Priscilla S. Kincaid-Smith MD, DSc |
University Hospital, Strasbourg, France |
Thierry P. Hannedouche, MD |
Hong Kong Study Using Valsartan in IgA Nephropathy (HKVIN) |
Philip Kam-Tao Li, MD, FRCP, FACP |
Nanfang Hospital, Southern Medical University |
Fan Fan Hou, MD, PhD |
Hospital 12 de Octubre, Madrid, Spain |
Manuel Praga, MD |
Captopril in Diabetic Nephropathy Study (CSG) |
Roger A. Rodby, MD, Richard D. Rohde, BS |
Reduction of Endpoints in NIDDM with theAngiotensin II Antagonist Losartan (RENAAL) |
Dick De Zeeuw, MD, PhD; Barry M. Brenner, MD; William Keane, MD |
Ramipril Efficacy In Nephropathy (REIN) |
Giuseppe Remuzzi, MD, FRCP, Piero Ruggenenti MD |
Irbesartan in Diabetic Nephropathy Trial (IDNT) |
Ed Lewis, MD; Lawrence G. Hunsicker, MD |
Appropriate Blood Pressure Control in Diabetes (ABCD) |
Robert W. Schrier, MD, Raymond O. Estacio, MD |
Ospedale M. Malpighi, Bologna, Italy |
Pietro Zucchelli, MD |
Modification of Diet in Renal Disease (MDRD) Study A and B |
Gerald Beck, PhD |
Ramipril Efficacy In Nephropathy (REIN-2) |
Giuseppe Remuzzi, MD, FRCP; Piero Ruggenenti MD |
University Hospital Gasthuisberg, Leuven, Belgium |
Bart Maes, MD, PhD |
Mayo Clinic, Rochester, Minnesota, USA |
James Donadio, MD; Fernando Fervenza, MD |
New York Presbyterian Hospital, Columbia University, New York, USA |
Gerald B. Appel, MD; Gershon Frisch, MD |
Euro Lupus Nephritis Trial (ELNT) |
Frédéric A. Houssiau, MD, PhD |
University of Hong Kong, Queen Mary Hospital |
Tak-Mao Chan MD |
Lupus Nephritis Collaborative Study (LNCS) |
Edmund Lewis, MD; John M. Lachin, ScD |
University of Toronto |
Daniel C. Cattran, MD, FRCPC |
IRCCS Istituto Humanitas, Milan, Italy |
Claudio Ponticelli, MD; PatriziaPasserini, MD; Gabriella Moroni, MD; Giuseppe Montogrino, MD |
GrupoEspañol de estudio de la Nefropatía Membranosa_ |
Manuel Praga, MD |